Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)

Updated

Adaptin Bio (APTN) posted Other Non Operating Income of $326,345 for Q1 2026, unchanged from $326,345 a year earlier.

Analysis

Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026) Analysis & Trends

Since Q1 2024, Adaptin Bio has reported Other Non Operating Income for 6 quarters.

  • In prior years, Adaptin Bio's Other Non Operating Income was -$194,537 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 326,345.00
Mar 31, 2025 326,345.00
Dec 31, 2024 -185,782.00
Sep 30, 2024 -6,249.00
Jun 30, 2024 -2,373.00
Mar 31, 2024 -133.00
API Access

Adaptin Bio Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APTN&period=max&api_key=YOUR_API_KEY